Should folic acid be given to women treated with valproic acid and/or carbamazepine?;Faut-il prescrire de l'acide folique aux femmes traitees par acide valproique et/ou carbamazepine? Acide folique et grossesse chez l'epileptique

Revue Neurologique

Volumn 155, Issue 3, 1999, Pages 220-224

  Champel, V ^b   Radal, M ^b   Moulin Vallez, M ^b   Jonville Bera A P ^b   Autret Leca, E ^a  

^a CHU BRETONNEAU   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CARBAMAZEPINE; FOLIC ACID; RETINOL; SPECIAFOLDINE; UNCLASSIFIED DRUG; VALPROIC ACID; ZEDENE C;

ANTICONVULSANT THERAPY; ARTICLE; CONCEPTION; EPILEPSY; HUMAN; MEDICAL DECISION MAKING; NEURAL TUBE DEFECT; TERATOGENICITY; TREATMENT PLANNING; VITAMIN SUPPLEMENTATION;

ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSY; FEMALE; FOLIC ACID; HUMANS; NEURAL TUBE DEFECTS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; RISK ASSESSMENT;

EID: 0032954813     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Anonyme (1991a). Interim CDC recommendations for folic acid supplementation for women-august 1991. Jama 266 (9): 1 191
2. Anonyme (1991b). Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 338: 131-7
3. Anonyme (1993a). Commission on genetics, pregnancy, and the child international league against epilepsy. Guidelines for the care of women of childbearing age with epilepsy. Epilepsia 34: 588-9
4. Anonyme (1993b). Folate and neural tube defects: US policy evolves. Nutr Rev 51: 358-61
5. Anonyme (1993c). Recommendations for use of folic acid to reduce number of spina-bifida cases and other neural tube defects. Jama 269: 1 233-8
6. Anonyme (1994). Nutrition in pregnancy: FDA proposes folic acid fortification and labeling. Nutr Res 13: 1-2
7. Anonyme (1995a). Folic acid and the prevention of neural tube defects. BMJ 311: 256-7
8. Anonyme (1995b). Prevention program for reducing risk for neural tube defects - South Carolina, 1992-1994. Jama 273: 1 485-5
9. Anonyme (1995c). Société Française de Pédiatrie. Comité de nutrition. Acide folique et grossesse. Arch Pédiatr 2: 173-81
10. BIALE T, LEWENTHAL H (1984). Effect of folic acid supplementation on congenital malformations due to anticonvulsive drugs. Eur J Obstet Gynecol Reprod Biol 18: 211-6
11. BOWER C, STANLEY FJ (1989). Dietary folate as a risk factor for neuraltube defects: evidence from a case-control study in Western Australia. Med J Aust 150; 11: 613-9
12. BRODIE MJ, DICHTER MA (1996). Antiepileptic drugs. N Eng J Med 334: 168-75
13. BUNDUKI V, DOMMERGUES M, ZITTOUN J, et al. (1995). Maternal-fetal folate status and neural tube defects: a case control study. Biol Neonate 67: 154-9
14. BURK DT, MIRKES PE (1994). Summary of the 1993 teratology society public affairs committee symposium: "folic acid prevention of neural tube defects: public policy issues". Teratology 49: 239-41
15. BUTTERWORTH CE, TAMURA T (1989). Folic acid safety and toxicity: a brief review. Am J Clin Nutr 50: 353-8
16. CAMPBELL NRC (1996). How safe are folic acid supplements? Arch Intern Med 156: 1 638-44
17. CORNEL MC, SCHRIJVERS P, DŒKHIE S, et al. (1996). Thresholds for periconceptional folic acid use in the netherlands. Pharmacoepidemiology and Drug Saf 54; S1-S119
18. CZEIZEL AE (1993). Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ 306: 1 645-8
19. CZEIZEL AE (1996). Prevention of neural tube defects. CNS Drugs 5: 399-412
20. CZEIZEL AE, DUDAS I (1992). Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Eng J Med 327: 1832-5
21. DANSKY LV, ANDERMANN E, ROSENBLATT D, et al. (1987). Anticonvulsivants, folate levels and pregnancy outcome: a prospective study. Ann Neurol 21: 176-82
22. DE JONG-VAN DEN BERG LTW, CORNEL MC, TYMSTRA T, BUITENDIJK SE (1995). Folate prophylaxis in pregnancy. Lancet 346: 1 227-8
23. DELGADO-ESCUETA AV, JANZ D (1992). Consensus guidelines: preconception counseling management, and care of the pregnant woman with epilepsy. Neurology 42 (Suppl 5): 149-160
24. FRASER JL, WATT HJ (1964). Megaloblastic anemia in pregnancy and the puerperium. Am J Obstet Gynecol 89: 532-4
25. GŒTSCH C (1962). An evaluation of aminopterin as an abortifacient. Am J Obstet Gynecol 83: 1 474-6
26. GOUJARD J (1995). Acide folique et prévention des anomalies de fermeture du tube neural. In: Pons G, Cabrol D, Tournaire M, eds Springler Verlag. Les traitements médicamenteux du fœtus. pp 229-36, Paris
27. GUIDOLIN L, VIGNOLI A, CANEVINI MP, et al. (1996). Worsening in seizure frequency and severity in relation to folic acid administration: case report. Epilepsia 37(Suppl. 4): 45 [abstract]
28. HIILESMAA VK, TERAMO K, GRANSTRÖM ML, BARDY AH (1983). Serum folate concentrations during pregnancy in women with epilepsy: relation to antiepileptic drug concentrations, number of seizures, and fetal outcome. BMJ 287: 577-9
29. JONES KL, LACRO RV, JOHNSON KA, ADAMS J (1989). Pattern of malformations in children of women treated with carbamazepine during pregnancy. N Eng J Med 320: 1 661-6
30. KÄLLEN AJB (1994). Maternal carbamazepine and infant spina bifida. Reprod Teratology 8: 203-5
31. KIRKE PN, DALY Le, ELWOOD JH for the Irish vitamin study group (1992). A randomised trial of low dose folic acid to prevent neural tube defects. Arch Dis Child 67: 1 442-6
32. KIRKE PN, DALY Le, MOLLOY A, et al. (1996). Maternal folate status and risk of neural tube defects. Lancet 348: 67-8
33. LAURENCE KM, JAMES N, MILLER MH, et al. (1981). Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. BMJ 282: 1 509-11
34. LINDHOUT D, SCHMIDT D (1986). In-utero exposure to valproate and neural tube defects (letter). Lancet 8494: 1 392-3
35. MARTINEZ-FRIAS ML, RODRIGUEZ-PINILLA E (1992). Folic acid supplementation and neural tubs defects. Lancet 340: 620
36. MILLS JL, MC PARTLIN JM, KIRKE PN, et al. (1995). Folate and neural tube defects: toward a mechanism. Lancet 345: 149-51
37. MILLS JL, RHOADS GG, SIMPSON JL, et al. (1989). The absence of a relation between the periconceptional use of vitamins and neural tube defects. New Eng J Med 321: 430-5
38. MILUNSKY A, JICK H, JICK S, et al. (1989). Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. Jama 262: 2 847-52
39. MULINARE J, CORDERO JF, ERICKSON D, BERRY R (1988). Periconceptional use of multivitamins and the occurence of neural tube defects. Jama 260 (21): 3141-5
40. NORRIS JW, PRATT RF (1974). Folic acid deficiency and epilepsy. Drugs 8: 366-85
41. O'BRIEN MD, GILMOUR-WHITE S (1993). Epilepsy and pregnancy. BMJ 307: 492-5
42. OAKESHOTT P (1994). Prevention of neural tube effects. Lancet 343: 123
43. OGAWA Y, KANEKO S, OTANI K, et al. (1991). Serum folic acid levels in epileptic mothers and their relationship to congenital malformations. Epilepsy Res 8: 75-8
44. ROBERT E (1983). Valproic acid in pregnancy. Association with spina bifida. A preliminary report. Clin Pediatr 22: 336
45. ROBERT E, KÄLLEN B (1994). In utero exposure to carbamazepine effects on the fetus. Issues Rev Teratology 7: 37-55
46. ROSA FW (1991). Spina bifida in infants of women treated with carbamazepine during pregnancy. N Eng J Med 324: 674-7
47. ROSENBERG IH (1992). Folic acid and neural tube defects. Time for action? New Eng J Med 327: 1 875-7
48. SHAW GM, LAMMER EJ, WASSERMAN CR, et al. (1995a). Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 345: 393-6
49. SHAW GM, SCHAFFER D, VELIE EM, et al. (1995b). Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects [see comments]. Epidemiology 6; 3: 219-26
50. SMITH MD, CARL GF (1982). Interaction between folates and carbamazepine or valproate in the rat. Neurology 32: 965-9
51. SMITHELLS RW, SELLER MJ, HARRIS R, et al. (1983). Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 7: 1 027-31
52. SMITHELLS RW, SHEPPARD S, WILD J, SCHORAH CJ (1989). Prevention of neural tube defect recurrences in Yorkshire: final report. Lancet ii: 498-9
53. SUTCLIFFE M, SCHORAH CJ, PERRY A, WILD J (1993). Prevention of neural tube defects. Lancet 342: 1 174
54. VERGEL RG, SANCHEZ LR, HEREDERO BL, et al. (1990). Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat Diagn 10: 149-52
55. WERLER M, SHAPIRO S, MITCHELL A (1993). Periconceptional folic acid exposure and risk of occurent neural tube defects. Jama 269: 1 257-61
56. WINSHIP KA, CAHAL DA, WEBER JC, GRIFFIN JP (1984). Maternal drug histories and central nervous system anomalies. Arch Dis Child 59; 11: 1 052-60